Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL
Abstract Casitas B-lineage lymphoma (CBL) is an E3 ubiquitin ligase and a molecule of adaptor that we have shown is important for non-small-cell lung cancer (NSCLC). We investigated if MET is a target of CBL and if enhanced in CBL-altered NSCLC. We showed that CBL wildtype cells have lower MET expre...
Enregistré dans:
Auteurs principaux: | Yi-Hung Carol Tan, Tamara Mirzapoiazova, Brian M. Won, Li Zhu, Minu K. Srivastava, Everett E. Vokes, Aliya N. Husain, Surinder K. Batra, Sherven Sharma, Ravi Salgia |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/16f501031f654eb7b913e9777d40b719 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Downregulation of Src-family tyrosine kinases by Srcasm and c-Cbl: A comparative analysis
par: Vivian Lee, et autres
Publié: (2021) -
The role of the e3 ligase cbl-B in murine dendritic cells.
par: Stephanie Wallner, et autres
Publié: (2013) -
Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL
par: Manuel Olazábal-Morán, et autres
Publié: (2021) -
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
par: Ana S. Guerreiro Stucklin, et autres
Publié: (2019) -
A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients
par: Jean-Louis Guéant, et autres
Publié: (2018)